CRISPR Therapeutics AG Equity-NMS: CRSP

$- -32.66 (January 1, 1970)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Error in Fetching Data, Please retry later.
Previous close :$32.66
Open :$31.95
Today's high :$32.99
Today's low :$30.96
52W low :$30.96
52W high :$67.88
EPS(TTM): :-4.34
Shares O/S :85.77 M
Market cap :2.79 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
CRISPR Therapeutics AG $- +0.3% - 2.79B

Frequently Asked Questions

What is the share price of CRISPR Therapeutics AG today?

CRISPR Therapeutics AG (CRSP) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About CRISPR Therapeutics AG

CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.